Pfizer
By Bernhard Warner and Alan MurrayMarch 28, 2022
By Sophie MellorMarch 23, 2022
HealthThe weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By Andrew MarquardtMarch 15, 2022
HealthChina just locked down 50 million people amid ‘stealth Omicron’ fears. The former FDA head predicts what happens next
By Marco Quiroz-GutierrezMarch 15, 2022
By Riley Griffin and BloombergMarch 14, 2022
HealthPfizer CEO says new COVID variants might make four—or more—vaccine doses ‘necessary’ for returning to normal
By Nicholas GordonMarch 14, 2022
NewslettersPfizer CEO on cracking COVID: ‘Companies that stay true to their purpose perform far better’
By Bernhard Warner and Alan MurrayMarch 8, 2022
HealthScientists have discovered 16 new genetic markers that predispose you to severe illness from COVID
By Andrew MarquardtMarch 7, 2022
HealthThe U.S. is about to approve a fourth COVID vaccine that could be a silver bullet solution to the anti-vax crisis
By Andrew MarquardtMarch 7, 2022
HealthDo you need another COVID booster? Here’s what experts say you should do to protect yourself against potential new variants
By Andrew MarquardtMarch 3, 2022
HealthEveryone is planning for a COVID-free summer. But epidemiologists say a new variant could emerge at any time.
By Tristan Bove and Andrew MarquardtMarch 1, 2022
By James Paton, Deirdre Hipwell and BloombergFebruary 16, 2022
Most Popular
